Once-daily treatment for canine atopic dermatitis
Delivers 6-in-1 parasite protection for cats
Valuable discounts, expert information, and tips
See how injectable medications offer value beyond the prescription
The first and only FDA-Approved veterinary antiemetic
The first long-lasting monoclonal antibody therapy for canine atopic dermatitis
Vaccination for the prevention of respiratory disease caused by BRSV
The beef industry’s No. 1 branded preconditioning program
Exclusive pricing program for Cattle producers
Outstanding protection against costly respiratory and reproductive diseases
Treatment and control of gastrointestinal roundworms, lungworms, eyeworms, grubs, sucking lice and mange mites
Innovative food safety products that help deliver a farm-to-fork solution for beef
The most comprehensive guarantee available
First and only FDA-approved antibiotic for horses that offers a full course of therapy in just two doses
Annual vaccination with CORE EQ INNOVATOR helps provide the protection your horse needs
Treats and controls encysted small strongyles, bots and roundworms. QUEST PLUS contains an additional active ingredient for efficacy against tapeworms
Patented and scientific method of determining fair service pricing to improve your clinic's profitability
Connect directly to valuable dairy management resources and experts
The most "veterinarian recommended" and "producer used" prostaglandin in the market
Delivers the peace of mind and profitability that come with no milk discard
Effective and convenient treatment for acute metritis in cattle
Working together to improve reproduction
One injection treats and controls swine respiratory disease for 7 days
Protect sows and gilts from costly breeding herd diseases — parvovirus, leptospirosis and erysipelas
The industry standard for in ovo technology.
Full automation solutions for hatchery automation
Prevention and control of necrotic enteritis, increased rate of weight gain and improved feed efficiency in poultry
for the prevention of coccidiosis in poultry
modified-live vaccine that helps poultry companies reduce their overall Salmonella load
Blood glucose monitoring system
Smart new diagnostics platform that can reinvent your in-house diagnostic routines
Detect Johne’s Disease with confidence in cattle and goat herds
Simple and effective detection of a deadly Feline Virus
Accurate, affordable and easy to use
Order Beef Genetics products online
Order Dairy Genetics products online
Delivers reliable predictions of genetic merit based on test results of core traits
Represents the latest advancement in Angus genotyping technology.
Find an upcoming class
Become a more effective leader
Looking for a tailored experience?
Earn continuing education credits and stay current on industry developments with Zoetis’ convenient, on-demand learning solutions.
Veterinarians, Veterinarian Techs, Business Owners, and Farm Hands
Launch your veterinary career
Veterinarian Students and Recent Graduates
Animal health expertise and results-focused resources for high-performing teams and leaders.
Veterinarians, Dairy producers, Beef producers, Equine Specialists, Pork producers, Poultry producers, Managers, Business Owners and Staff
Home / NEWS & MEDIA / Vanguard® Rapid Resp Becomes First and Only Vaccine Licensed to Provide Dogs with One-Year Duration of Immunity from Three Canine Infectious Respiratory Diseases
Vaccine helps protect against Bordetella bronchiseptica, canine adenovirus type 2 and canine parainfluenza virus infections
PARSIPPANY, N.J. — December 18, 2017 — Zoetis today announced that the United States Department of Agriculture (USDA) has granted the Vanguard® Rapid Resp intranasal vaccine line one-year duration of immunity (DOI) claims for the Bordetella bronchiseptica (Bb), canine adenovirus type 2 (CAV-2) and canine parainfluenza virus (CPiV) fractions. Vanguard Rapid Resp is the first and only intranasal vaccine line in the United States that has been demonstrated to provide one year of protection against three important Canine Infectious Respiratory Diseases (CIRD). Additionally, the line is the broadest among 0.5 mL intranasal vaccines used in dogs in the United States.
“The demonstration of a one-year duration of immunity for all three antigens in Vanguard Rapid Resp represents an important step in the protection of dogs from CIRD. This new DOI confirms the efficacy of a single product that provides both rapid and durable protection against these important antigens in the CIRD complex,” said Stephan Carey, DVM, PhD, DACVIM, assistant professor of Small Animal Clinical Sciences at Michigan State University College of Veterinary Medicine.* “This extended DOI is essential in reducing morbidity and mortality from infectious respiratory disease among dogs in social or commingled environments such as boarding facilities and shelters.”
Infectious respiratory disease in dogs can be caused by many different pathogens, both bacterial and viral. In most instances, the clinical signs will be identical regardless of the infecting pathogen. Co-infections can also occur, leading to more severe symptoms, which makes identifying the proper treatment difficult.
“I am proud of the innovative science which has enabled Zoetis to gain 12-month protection claims for Bordetella bronchiseptica, canine adenovirus 2 (CAV-2) and canine parainfluenza virus (CPiV) fractions of Vanguard Rapid Resp vaccines,” said Annette Litster, BVSc, PhD, FANZCVS, MMed Sci, senior veterinary specialist, Veterinary Specialty Operations Team at Zoetis. “This demonstrates our determination to provide veterinarians with ever better solutions for their clients and canine patients in their care. A 12-month duration of immunity across all three antigens gives us even greater confidence in the protection provided by Vanguard Rapid Resp to help prevent these common and widespread infections.”
Vanguard Rapid Resp is available in three antigenic combinations (Bb + CPiV + CAV-2; Bb + CPiV; Bb only), and all of these choices can be administered with a syringe or a syringe-free applicator.
To learn more about Vanguard Rapid Resp, visit VanguardRapidResp.com.
About ZoetisZoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products, genetic tests, biodevices and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2016, the company generated annual revenue of $4.9 billion with approximately 9,000 employees. For more information, visit www.zoetis.com.
Reference:*Dr. Stephan Carey is a consultant to Zoetis.
Colleen White Zoetis 973-822-7203 firstname.lastname@example.org
Lindsey GoodmanArcher Malmo706email@example.com
Mon–Fri, 8am–8pm ET
You are leaving the country website to access another site in the group.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.
This site is intended for U.S. Animal Healthcare Professionals.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2019 Zoetis Services LLC. All rights reserved.